Patient-Reported Data Collection to Grow Through Medicare Drug Pricing Negotiations

A recent guidance from the US Centers for Medicare and Medicaid Services (CMS) stated that patient experiences will be factored into the upcoming Medicare drug pricing negotiations. As a result, patient-reported data collection is set to grow significantly. However, significant uncertainty surrounds the process and meeting as of yet unset parameters for the datya.

According to Jeannie Baumann, “At the same time, she [Esther Krofah of the Milken Institute] cautioned that the agency still needs to offer more details, such as how to submit data, how to structure the data so they’re meaningful to the agency, and the types of elements and content the CMS is looking to provide into its overall data package.”

To read more, click here.

(Source: Bloomberg Law, April 10^th, 2023)